Because IFN-γ robustly induces PD-L1 in myeloma plasma cells (42, 43), reduced PTPRG would be expected to prolong/augment STAT1 signaling and enhance PD-L1 induction, whereas higher PTPRG should blunt this response. The gene discussed is PTPRG; the disease is plasma cell myeloma.